The outbreak of COVID-19 pandemic had a negative impact on the market growth of psoriasis treatment. This can be attributed to the lockdown restrictions imposed by the governments of several nations to curtail the spread of the infection. In compliance with these restrictions, the global market for psoriasis treatment witnessed a decline as people restricted or postponed their dermatological treatments. However, the market began to revive in the latter part of 2020 with the receding pandemic. Apart from this, North America is expected to hold a significant share in the overall market growth over the forecast period. The market growth in the region is expected to be augmented by the prevalence of the disease in the region, especially in the US. In addition to this, the presence of a developed healthcare infrastructure in the region, along with the presence of an established network of pharmaceutical and biotechnology companies, and favourable government policies, are anticipated to drive the growth of the market in the region.
UCB, a leading biopharmaceutical company, recently announced that the European Commission (EC), recently granted the approval of BIMZELX in August 2021. BIMZELX (bimekizumab) is the first approved treatment in the European Union for the treatment of adults with moderate to severe plaque psoriasis. The first marketing authorisation of BIMZELX in the European region represents an expansion and dominance of UCB in the region, along with a vast opportunity for leading companies to introduce various treatments against psoriasis. Hence, such developments by leading market players are driving the growth of the psoriasis treatment industry. The market is further expected to be driven by the expansion and developments of market players like Johnson and Johnson Services Inc. (NYSE: JNJ) and Pfizer Inc. (NYSE: PFE).
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major players in the global psoriasis treatment market are AbbVie Inc., Novartis AG, Johnson and Johnson Services, Inc., Pfizer Inc., and Merc and Co., Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124